TREM2 INHIBITION REPROGRAMS MYELOID CELLS TO STIMULATE ANTI-TUMOR IMMUNITY THROUGH BOTH DIRECT AND INDIRECT MECHANISMS

被引：0

作者：

Sun, Rui ^{[1
]}

Han, Rowland ^{[1
]}

McCornack, Colin ^{[1
]}

Tabor, G. Travis ^{[1
]}

Hou, Jinchao ^{[1
]}

Cleary, Ryan ^{[1
]}

Mao, Diane ^{[1
]}

Liu, Qin ^{[1
]}

Schoch, Kathleen ^{[1
]}

Luo, Jingqin ^{[1
]}

Petti, Allegra ^{[2
]}

Miller, TImothy ^{[1
]}

Ulrich, Jason ^{[1
]}

Holtzman, David ^{[1
]}

Kim, Albert ^{[1
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

[2] Mass Gen Hosp, Boston, MA USA

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IMMU-28

引用

页数：1

共 50 条

[1] TREM2 RESTRAINS ANTI-TUMOR CELL ACTIVITY OF MYELOID CELLS IN GLIOBLASTOMA
Sun, Rui
Khan, Saad
Luo, Jingqin
McCornack, Colin
Chen, Yun
Jiang, Haowu
Mao, Diane D.
Yang, Alicia
Liu, Qin
Petti, Allegra
Holtzman, David
Kim, Albert
NEURO-ONCOLOGY, 2022, 24 : 138 - 139
[2] Myeloid Cells TREM Down Anti-tumor Responses
Bugler-Lamb, Aimee
Guilliams, Martin
CELL, 2020, 182 (04) : 796 - 798
[3] Direct and indirect anti-tumor mechanisms of Regressin®.
Filion, MC
Lépicier, P
Phillips, NC
Morales, A
JOURNAL OF UROLOGY, 1998, 159 (05): : 276 - 276
[4] TUNING THE TUMOR MICROENVIRONMENT BY REPROGRAMMING TREM1+MYELOID CELLS TO UNLEASH ANTI-TUMOR IMMUNITY IN SOLID TUMORS
Jahchan, Nadine
Ramoth, Hanna
Juric, Vladi
Mayes, Erin
Mankikar, Shilpa
Mehta, Ranna
Binnewies, Mikhail
Dash, Subhadra
Palmer, Rachael
Pollack, Joshua
Rudolph, Joshua
Canaday, Pamela
Haeggblom, Linnea
Santamaria, Carlos
Du, Xiaoyan
Reyno, Leonard
Baker, Kevin
Liang, Linda
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A900 - A900
[5] TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
Sun, Rui
Han, Rowland
McCornack, Colin
Khan, Saad
Tabor, G. Travis
Chen, Yun
Hou, Jinchao
Jiang, Haowu
Schoch, Kathleen M.
Mao, Diane D.
Cleary, Ryan
Yang, Alicia
Liu, Qin
Luo, Jingqin
Petti, Allegra
Miller, Timothy M.
Ulrich, Jason D.
Holtzman, David M.
Kim, Albert H.
SCIENCE ADVANCES, 2023, 9 (19)
[6] BET inhibition reprograms pancreatic cancer associated fibroblasts to promote anti-tumor immunity
Minocha, Trisha
Thomas, Alison
Olson, Brian M.
CANCER RESEARCH, 2023, 83 (07)
[7] TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapy
Di Luccia, Blanda
Molgora, Martina
Khantakova, Darya
Jaeger, Natalia
Chang, Hao-Wei
Czepielewski, Rafael S.
Helmink, Beth A.
Onufer, Emily J.
Fachi, Jose L.
Bhattarai, Bishan
Trsan, Tihana
Rodrigues, Patrick F.
Hou, JinChao
Bando, Jennifer K.
da Silva, Cristiane Secca
Cella, Marina
Gilfillan, Susan
Schreiber, Robert D.
Gordon, Jeffrey I.
Colonna, Marco
SCIENCE IMMUNOLOGY, 2024, 9 (95) : eadi5374
[8] TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy
Molgora, Martina
Esaulova, Ekaterina
Vermi, William
Hou, Jinchao
Chen, Yun
Luo, Jingqin
Brioschi, Simone
Bugatti, Mattia
Omodei, Andrea Salvatore
Ricci, Biancamaria
Fronick, Catrina
Panda, Santosh K.
Takeuchi, Yoshiko
Gubin, Matthew M.
Faccio, Roberta
Cella, Marina
Gilfillan, Susan
Unanue, Emil R.
Artyomov, Maxim N.
Schreiber, Robert D.
Colonna, Marco
CELL, 2020, 182 (04) : 886 - +
[9] Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2)
Jones, Brandon M.
Bhattacharjee, Surjyadipta
Dua, Prerna
Hill, James M.
Zhao, Yuhai
Lukiw, Walter J.
FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
[10] Inhibition of CD39 results in elevated ATP and activation of myeloid cells to promote anti-tumor immunity
Bowman, Christine E.
Chen, Ada
Juat, Damie
Parashar, Kaustubh
Clor, Julie
Singh, Hema
Kushwaha, Ritu
Handlos, Bryan
Liu, Suan
Kline, Janine
Zhao, Xiaoning
Kwon, Hyock Joo
Green, David
Young, Stephen W.
Fernandez-Salas, Ester
Walters, Matthew J.
Walker, Nigel P.
CANCER RESEARCH, 2022, 82 (12)

← 1 2 3 4 5 →